New Breakthrough in Lyme Disease Testing: What Clinicians Need to Know for Accurate Diagnosis
Why FDA-Cleared IGeneX ImmunoBlots May Finally Solve the Sensitivity Problems in Lyme Disease Diagnosis For clinicians on the front lines of Lyme disease, a groundbreaking development in Lyme testing has arrived. IGeneX’s IgM and IgG ImmunoBlot test kits have now received FDA clearance – a milestone that promises to transform Lyme disease diagnosis for the…
Read More →